Navigation Links
Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results
Date:4/14/2011

nsation expenses – per weighted average share0.27-Non-cash merger costs - per weighted average share0.03-Adjusted earnings per weighted average share of common stock0.820.57Outstanding weighted average shares21,780,71819,094,000About Global Pharm HoldingsGlobal Pharm Holdings Group, Inc. operates as a pharmaceutical distribution business in the People's Republic of China. Through its three subsidiaries, Shandong Global Pharm Co., Ltd., Tonghua Tongdetang Pharmaceutical & Medicinal Material Co., Ltd., and Anhui Xuelingxian Pharmaceutical Co., Ltd., the Group focuses on pharmaceutical related products distribution. In order to alleviate the impact on price inflation and maintain the supply stability of Traditional Chinese Medicine (TCM) raw materials, the Group also engages in the cultivation and processing of TCM herbs. Currently, Global Pharm owns GSP-certified, modern logistics distribution centers totally occupying 237,600 square feet and manages over 13,000 inventory products; and its sales network covers Shandong, Jilin, and Liaoning provinces, as well as other developed provinces in China. The Group intends to establish an integrated value chain in the pharmaceutical industry through strategic acquisitions within pharmaceutical production, distribution, and retail sectors. Global Pharm will achieve a solid distribution capacity and grow to be a major rapid-growing and profitable pharmaceutical company. For further information, please visit the Company's corporate website at http://www.globalpharmholdings.com.

Forward-looking Statements Certain statements set forth in this press release contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, our management as well as estimates and assumptions made by our management. Such statements reflect the current view of our management with respect to future events
'/>"/>

SOURCE Global Pharm Holdings Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols
2. Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will Present Four Abstracts Evaluating Safety and Efficacy at EASL
3. Reportlinker Adds Quantum Dots: Technologies and Global Markets
4. Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
5. Reportlinker Adds Global Nanobiotechnology Industry
6. Reportlinker Adds Global Biochips Industry
7. Top 5 Global Pharmaceutical Company Selects NewCardios QTinno for 2 Upcoming Phase I Drug Safety Trials
8. Global Growth Factors ( Blood And Tissue ) Industry
9. Global HPLC Systems & Accessories Industry
10. Global Specialty Enzymes Industry
11. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 GOJO, inventors of PURELL ® ... antibiotic stewardship at the White House Forum.  GOJO was ... organizations and stakeholders at the White House Forum to ... the emergence of antibiotic-resistant bacteria, detect resistant strains, preserve ... spread of resistant infections. "A primary prevention ...
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
(Date:6/2/2015)... LA (PRWEB) June 02, 2015 ... gene synthesis to improve protein expression, announced the formation ... includes six executives and entrepreneurs with a broad range ... industries. , The team includes: , Jimmy Roussel, ... , Roussel has a background in technology and marketing. ...
(Date:6/1/2015)... 1, 2015  Turing Pharmaceuticals AG announced that life ... , MD, MSc,  has joined the company as ... Salinas, who holds a medical degree as well ... of significant accomplishments in the pharmaceutical industry, and ... Salinas has played a leadership role in numerous ...
Breaking Biology Technology:GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3
... Aug. 6 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... the,discovery, development and commercialization of novel drugs in ... today,announced that it will host a conference call ... on Thursday, August 14, 2008 at 10:00,a.m. (EDT). ...
... Aug. 6 Denham Capital,("Denham") announced today ... million in VitAG,Corporation ("VitAG"). VitAG technology converts ... capable of competing with and,outperforming conventional fertilizers. ... biosolids-to-fertilizer manufacturing plants., "Denham,s investment in ...
... the biometrics company enabling applications for the ... alliance with Methode Electronics, Inc. One of ... includes being a solid Tier 1 automotive ... subsystem devices. Together, Methode and Lumidigm will ...
Cached Biology Technology:Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 2Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 3Denham Capital to Invest $60 Million in VitAG, Recycler of Municipal Biosolids 2 Lumidigm Signs Strategic Agreement with Methode Electronics : Automotive Supplier Invests in Biometric Component Development 2
(Date:5/20/2015)... DUBLIN , May 20, 2015 ... Markets ( http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the ... of the Global Iris Recognition Market" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service analyses ... across the government and commercial sectors, ...
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
(Date:5/11/2015)... JOSE, Calif. , May 11, 2015 /PRNewswire/ ... developer of human interface solutions, today announced the ... Vice President and Chief Financial Officer, reporting to ... Ali replaces Synaptics, current Chief Financial Officer, ... December 2014. Mr. Ali brings ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... University of Southampton and the Australian National University report that ... natural standards and at current rates may reach ... by 2200. The team used geological evidence of ... of natural sea-level rise. This was compared with historical tide-gauge ...
... have revealed the inner workings of the ozone hole ... chlorine in the stratosphere has not yet caused a ... years after the Montreal Protocol agreement limited human emissions ... the annual ozone hole and watched it essentially stabilize, ...
... 10, 2013 Spectrum Health will be the first ... in the nation to offer treatment with a newly ... for adult epilepsy patients whose seizures have not responded ... is an implantable therapeutic device designed to detect abnormal ...
Cached Biology News:What the past tells us about modern sea-level rise 2NASA reveals new results from inside the ozone hole 2NASA reveals new results from inside the ozone hole 3Spectrum Health to offer implantable neurostimulator for hard-to-treat epilepsy patients 2
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
Biology Products: